Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-Host Disease (GVHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02561520
What this trial is testing

Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD

Who this might be right for
Graft-versus-host Disease
Ladan Espandar
Very early researchLooking for participantsNCT07253259
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD)

Who this might be right for
cGVHD
Grit Biotechnology 36
Early research (Phase 1)WithdrawnNCT02743546
What this trial is testing

Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Looking for participantsNCT06756061
What this trial is testing

Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity

Who this might be right for
GVHD - Graft-Versus-Host DiseaseNeoplasmsHaematopoietic Stem Cell Transplantation
Byung-Sik Cho 88
Early research (Phase 1)Not Yet RecruitingNCT07484113
What this trial is testing

IL6-receptor Inhibitor Iwith Belumosudil for the Treatment of Belumosudil-refractory cGVHD

Who this might be right for
cGVHD
Stanford University 10
Early research (Phase 1)Study completedNCT00967096
What this trial is testing

Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)

Who this might be right for
MalignancyBone Marrow Transplantation
Emory University 20
Large-scale testing (Phase 3)Study completedNCT01002742
What this trial is testing

Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

Who this might be right for
Graft-versus-Host DiseaseImmune System Disorders
Medical College of Wisconsin 236
Not applicableWithdrawnNCT01569373
What this trial is testing

Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Who this might be right for
Blood Stem Cell Transplant Failure
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT04910152
What this trial is testing

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Who this might be right for
Acute Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
Hannah Choe, MD 2
Not applicableEnded earlyNCT01976598
What this trial is testing

Sub-Sensory Intraspinal Neurostimulation Therapy

Who this might be right for
Back PainBack Pain With RadiationPain in Leg, Unspecified
Algos Clinical Development Thomas L. Yearwood, MD, PhD 1
Testing effectiveness (Phase 2)Ended earlyNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 2
Not applicableEnded earlyNCT00489216
What this trial is testing

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids

Who this might be right for
Graft Versus Host Disease
UNC Lineberger Comprehensive Cancer Center 2
Not applicableEnded earlyNCT01455948
What this trial is testing

Canadian Health Economics, Outcome, and Effectiveness Comparison of Treatment in Patients With Chronic Rhinosinusitis

Who this might be right for
Chronic Rhinosinusitis
Integra LifeSciences Corporation 25
Testing effectiveness (Phase 2)Study completedNCT00810602
What this trial is testing

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

Who this might be right for
Hematologic MalignanciesGraft vs Host Disease
Pavan Reddy, MD 61
Testing effectiveness (Phase 2)Ended earlyNCT01875237
What this trial is testing

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Who this might be right for
LeukemiaMyelomaMyeloproliferative Diseases
M.D. Anderson Cancer Center 3
Not applicableActive Not RecruitingNCT06458127
What this trial is testing

Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host DiseaseChronic GVHDcGVHD
Massachusetts General Hospital 10
Large-scale testing (Phase 3)Study completedNCT02913261
What this trial is testing

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Corticosteroid Refractory Acute Graft vs Host Disease
Novartis Pharmaceuticals 310
Not applicableStudy completedNCT05131945
What this trial is testing

GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study)

Who this might be right for
ThoracentesisPleural Effusions, ChronicPulmonary Edema
M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)WithdrawnNCT04059757
What this trial is testing

Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD

Who this might be right for
Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)
Leland Metheny
Not applicableWithdrawnNCT06200441
What this trial is testing

Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease

Who this might be right for
Acute Myeloid Leukemia, AdultGraft Versus Host DiseaseEndothelial Dysfunction
Ugur Arzu Kulu
Next Page